Bellicum Pharmaceuticals, Inc. Announces New Director, Executive Management Appointments

HOUSTON--(BUSINESS WIRE)--Bellicum Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing novel cellular immunotherapies, today announced the appointment of a new Director and two senior executives to its management team.

•Jon P. Stonehouse has been elected to Bellicum’s Board of Directors. Jon currently serves as President and Chief Executive Officer of BioCryst Pharmaceuticals, Inc.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC